上海交通大学学报（医学版）

›› 2011, Vol. 31 ›› Issue (3): 365-.doi: 10.3969/j.issn.1674-8115.2011.03.028

• 论著（卫生事业管理） • 上一篇    下一篇

肺癌日间化疗经济学分析及可行性探讨

冯 运1, 陆 舜2, 徐 蕾3, 施 旖4, 宋正波2, 陈智伟2   

  1. 上海交通大学附属胸科医院 1.院长办公室, 2.上海市肺部肿瘤临床医学中心, 3.科教科, 4.医务科, 上海 200030
  • 出版日期:2011-03-28 发布日期:2011-03-29
  • 通讯作者: 陈智伟, 电子信箱: lungcancer2007@yahoo.com.cn。
  • 作者简介:冯 运（1961—）, 男, 研究员, 硕士, 硕士生导师；电子信箱: fengyun655@126.com。

Economic analysis and feasibility of ambulatory chemotherapy for lung cancer

FENG Yun1, LU Shun2, XU Lei3, SHI Yi4, SONG Zheng-bo2, CHEN Zhi-wei2   

  1. 1.Director Office, 2.Lung Tumor Clinical Medical Center, 3.Department of Science and Education, 4.Department of Medical Affairs, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China
  • Online:2011-03-28 Published:2011-03-29

PDF (PC)

1838

摘要：

目的 探讨肺部肿瘤病房使用新模式，通过增加床位周转，缓解目前肺部肿瘤患者住院难的问题，同时在保证患者疗效情况下进一步降低患者的医疗费用，节省医疗开支。方法 统计上海交通大学附属胸科医院肺部肿瘤医学中心2009年1月—2009年4月接受日间化疗患者（n=249）的治疗费用、住院时间及化疗相关不良反应的发生情况，以同期接受普通化疗的患者（n=827）作为对照组。结果 日间化疗组患者的平均住院时间和治疗总费用均显著低于与普通化疗组，差异具有统计学意义（4.30 d和13.7 d，6 751.87元和14 198.03元，均P<0.01）。两组化疗相关不良反应相似，日间化疗组白细胞降低比例高于普通化疗组，胃肠道反应（呕吐）发生比例低于普通化疗组，差异均具有统计学意义（P<0.01）。结论 日间化疗有效缩短了患者的住院时间，减少了住院费用，可作为常规住院化疗外的治疗新模式进一步推广。

关键词: 肺癌, 日间化疗, 经济学

Abstract:

Objective To explore the new method to achieve higher turnover rate of wards and less medical cost for treatment of lung caner, in order to accommodate with the limited medical resources. Methods Analysis of medical cost, time of hospitalization and prevalences of chemotherapy-related adverse effects were performed in 249 patients with ambulatory chemotherapy (ambulatory chemotherapy group) during January 2009 to April 2009 in Lung Tumor Clinical Medical Center, Shanghai Chest hospital, Shanghai Jiaotong University, and 827 patients with routine chemotherapy during the same period were served as control group. Results The mean time of hospitalization and total medical cost of ambulatory chemotherapy group were significantly lower than those of control group (4.30 d vs 13.7 d and 6 751.87 yuan vs 14 198.03 yuan, P<0.01 for both). The chemotherapy-related adverse effects were similar in both groups, with the prevalence of leukopenia being higher and that of vomiting being lower in ambulatory chemotherapy group (P<0.01 for both). Conclusion Ambulatory chemotherapy can reduce the time of hospitalization and medical cost, and is recommended as the new model for treatment of lung cancer.

Key words: lung cancer, ambulatory chemotherapy, economics